Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more
MarketWatch
MarketWatch
MarketWatch
CNBC
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.